<DOC>
	<DOCNO>NCT01104584</DOCNO>
	<brief_summary>The purpose study look efficacy ( work ) safety gadobutrol use obtain MR image breasts.Women recent diagnosis breast cancer mammogram ( X-ray examination breast ) may benefit MRI breast MRI may detect additional breast cancer</brief_summary>
	<brief_title>Efficacy Safety Gadobutrol 1.0 Molar ( Gadovist ) Breast Magnetic Resonance Imaging ( MRI )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Recent histologically proven diagnosis breast cancer obtain XRay Mammography ( XRM ) breast ( accord American College Radiology [ ACR ] perform longer 6 week prior enrollment study ) refer contrastenhanced Magnetic Resonance Mammography ( MRM ) prior surgery breast . female , digital XRM require follow criterion meet : a. patient young 50 year ; b. patient heterogeneously extremely dense breast ; c. postmenopausal ( postmenopause define least 12 month prior inclusion without menstruation ) . female childbearing potential , MRM perform 714th day menstrual cycle . estimate glomerular filtration rate ( eGFR ) value &gt; /= 60 mL/min/1.73m^2 derive serum creatinine result within 2 week prior study enrollment . female patient pregnant lactate contraindication MRM examination ( e.g . metal implant , phobia ) use gadoliniumcontaining contrast agent . receive contrast agent within 24 hour prior study MRM , schedule receive contrast agent within 24 hour study MRM . severe cardiovascular disease ( e.g. , know long QT syndrome , acute myocardial infarction [ &lt; 14 day ] , unstable angina , congestive heart failure New York Heart Association class IV ) acute stroke ( &lt; 48 hour ) ) . acute renal insufficiency severity due hepatorenal syndrome perioperative liver transplantation period acute chronic moderate severe renal insufficiency ( glomerular filtration rate &lt; 60 mL/min/1.73m^2 ) . receive chemotherapy hormonal therapy breast cancer within 6 month . receive hormone replacement therapy within 4 week prior study drug administration . schedule likely require surgery and/or biopsy time period 24 hour follow study drug application prior excisional biopsy breast surgery le 6 month enrollment XRM study MRM</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Gadobutrol-enhanced MRI</keyword>
	<keyword>Mammography</keyword>
	<keyword>Diagnostic Imaging</keyword>
</DOC>